Iris Completes Purchase of AlliedPath for Up to $6M

The deal gives Iris a CLIA-certified molecular pathology laboratory and a direct commercial channel for acceleration of its NADiA platform.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories